Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Guardant Health, Inc. publishes a filing, an earnings call transcript or a press release.

Get GH alerts

About Michael Bell

Michael Bell is recorded as CFO at Guardant Health, Inc. (GH). The newest filing on record that lists Michael Bell as CFO at Guardant Health, Inc. (GH) is dated April 28, 2026. The proxy statement of Guardant Health, Inc. reports total compensation of $4,123,993 for Michael Bell in fiscal 2023, including a base salary of $482,000. Disclosed compensation is on record for 3 fiscal years. Michael Bell has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for Guardant Health, Inc. on March 11, 2026. Guardant Health, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Guardant Health, Inc. includes AmirAli Talasaz (CEO and Board Member), Helmy Eltoukhy (CEO, Chairman and Board Member), Ines Dahne-Steuber (COO) and 7 others.

Michael Bell on recent calls

“I mean, it's broadly in the right ballpark. And, yeah, it's been our fastest-growing oncology product by volume for the last few years. And we expect it's going to continue to be so this year.”
CFO, Barclays 28th Annual Global Healthcare Conference ·
“Starting with our financial results on slide 14. Total revenue for the fourth quarter of 2023 grew 22% to $155.1 million compared to $126.9 million in the prior year quarter.”
CFO, Guardant Health, Inc. Q4 FY2023 Earnings Call ·
“Starting with Guardant360 ASP on Slide 12. As Helmy outlined, we're starting to see the positive impact on Guardant360 ASP from commercial payer coverage wins that have recently received confirmed and proposed Medicare price increases to Guardant360 LDT.”
CFO, Guardant Health, Inc. Q3 FY2023 Earnings Call ·
“Turning to Slide 12 to review our financial results. Total revenue for the second quarter of 2023 grew 26% to $137.2 million compared to $109.1 million in the prior year quarter.”
CFO, Guardant Health, Inc. Q2 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Guardant Health, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Guardant Health, Inc. (GH) $482,000 $4,123,993
2022 Guardant Health, Inc. (GH) $466,077 $1,977,712
2021 Guardant Health, Inc. (GH) $439,616 $6,459,981

Recent activity